InvestorsHub Logo

moneybags888

07/26/21 9:39 PM

#11381 RE: Richard T #11380

Where on earth did you come up with that theory ? Based on what ? Curious TIA.

Biotechotcguy

07/26/21 9:45 PM

#11382 RE: Richard T #11380

Huhhhhhh????

no_ur_stox

07/27/21 1:10 PM

#11397 RE: Richard T #11380

Hope you don't mind me offering my 2 cents.

Not sure what you're implying by this: "So if there is a 1/100 reverse merger with Hypur" - the reverse merger is a standalone, and although it could potentially impact how a merger deal is structured, the overall agreement will be based on valuation, along with the structured debt. At this point one could only guess, as to what the cost would be to shareholders - it's very difficult to assess a merger agreement, without knowing all the internals of HYPUR.

That said, I have given this subject some thought, and the question is: what exchange rate would be negotiated for controlling interest/outstanding shares in BLPG? We do know that HYPUR has 200 M Class A Shares, and 24 M Class B Shares, but the focus should be on the Class A shares – what would be the conversion/exchange rate of the Class A Shares for each BLPG share? At this point it’s hard to determine, but, I would venture to say that should a merger take place, Galvin has already determined the exchange rate, which could very well have a direct connection to the recent reverse split – that said, HYPUR will haver the upper hand due to the outstanding structured debt, along with their overall valuation.

Lastly, it’s becoming more evident why the BLPG preferred shares heavily outweighs the common, which I believe is tied to the longer-term goal – I’m thinking the preferred will be utilized to grow the bottom line, which could potentially be connected to a merger, uplist, along with the plan to attract a suitor. (the latter, if it comes to pass will make the preferred VERY attractive and quite valuable)